RISE Integrated Mental Health in York, Maine, offers ketamine therapy for trauma and depression, attracting patients ...

Oral ketamine from Douglas Pharma shows efficacy in phase 2 treatment-resistant depression trial and will move into pivotal trials.

When Matt Thierfelder began his career as a Vancouver firefighter in 1994, the weight of unspoken rules hung over him: Don’t show weakness and don’t be vulnerable.

Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable ...

Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.

Spravato is the first ketamine-based medicine approved to treat depression, and also the first of a new class of glutamate NMDA receptor-targeting drugs that have ended a decades-long drought at ...

The acquisition of Cohen and Associates, a respected interventional psychiatry practice, by NRx subsidiary HOPE Therapeutics, is expected ...

Acadia Pharmaceuticals is working on its next-generation Nuplazid and, for CEO Catherine Owen Adams, the journey is personal.